CALT Chart
See on advanced chart >
About
Calliditas Therapeutics AB was formed in February 20, 2004. The company is a clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic...
Read More
- HighlightA commercial stage biopharma company based in Stockholm, Sweden focused on identifying, developing and commercializing novel treatments in orphan indications
- ExchangeNASDAQ
- Listing Date06/05/2020
- Established Date02/20/2004
- Full-time Employees178
- AddressKungsbron 1 C8 SE-111 22 Stockholm Sweden 11122
- Tel46-8-4113005
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Pharmaceuticals
